DNA甲基化异常与恶性血液病关系的研究现状
被引量:2
摘要
DNA甲基化是表观遗传调控的分子基础之一,DNA甲基化异常与恶性血液病的发生、发展有关。本文综述了多种功能基因甲基化异常和恶性血液病的关系及去甲基化药物治疗恶性血液病的现状和前景,旨为恶性血液病的治疗提供新的思路。
出处
《广东医学院学报》
2011年第2期200-203,共4页
Journal of Guangdong Medical College
参考文献22
-
1Martinez-Delgado B,Melendez B,Cuadros M,et al.Frequent inactivation of the p73 gene by abnormal methylation or LOH in non-Hodgkin's lymphomas[J].Int J Cancer,2002,102(1):15-19.
-
2Kawano S,Miller C W,Gombart A F,et al.Loss of p73 gene expression in leukemias/ lymphomas due to hypermethylation[J].Blood,1999,94(3):1113-1120.
-
3Katzenellenbogen R A,Baylin S B,Herman J G.Hypermethylation of the DAP-Kinase CpG island is a commol alteration in B-cell malignancies[J].Blood,1 999,93(12):4347-4353.
-
4Roman-Gomez J,Castillejo J A,Jimenez A,et al.5' CpG island hypermethylation is associated with transcriptional silencing of the p21(CIP1/WAF1/SDI1)gene and confers poor prognosis in acute lymphoblastic leukemia[J].Blood,2002,99(7):2291-2296.
-
5Solomon P R,Munirajan A K,Tsuchida N,et al.Promoter hypermethylation analysis in myelodysplastic syndromes.Diagnostic & prognostic implication[J].Indian J Med Res,2008,127(1):52-57.
-
6Herman J G,Jen J,Merlo A,et al.Hypermethylation-associated inactivation indicates a tumor suppressor role for p15 INK4B[J].Cancer Res,1996,56(4):722-727.
-
7Christiansen D H,Andersen M K,Pedersen-Bjergaard J.Methylation of pl5INK4B is common is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemia[J].Leukemia,2003,17(9):1813-1819.
-
8Mateos M V,Garcia-Sanz R,López-Pérez R,et al.p16/INK 4a gene inactivation by hypermethylation is associated with aggressive variants of monoclonal gammopathies[J].Hematology Journal,2001,2(3):146-149.
-
9Garcia M J,Martinez Delgado-B,Cebrian A,et al.Different incidence and pattern of p15INK4b and p16INK4a promoter region hypermethylation in Hodgkin's and CD30-Positive non-Hodgkin's lymphomas[J].Am J PathoL 2002,161(3):1007-1013.
-
10Mollemann M,Wolter M,Felsberg J,et al.Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors[J].Int J Cancer,2005,113 (3):379-385.
二级参考文献5
-
1吕联煌 梁玉英 等.雷公藤内酯醇治疗急性白血病的研究[J].血液病实验与临床,1991,3:1-3.
-
2Kiviharju TM,Lecane PS,Sellers RG,et al. Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells. Clin Cancer Res,2002, 8:2666-2674.
-
3Zhao G, Vaszar LT, Qiu D, et al. Anti-inflammatory effects of triptolide in human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol, 2000, 279: L958-L966.
-
4Shamon LA, Pezzuto JM, Graves J M, et al. Evaluation of the mutagenic, cytotoxic, and antitumor potential of triptolide, a highly oxygenated diterpene isolated from Tripterygium wilfordii. Cancer Lett, 1997,112: 113-117.
-
5金洁,MHauberg,林雄斌,RParwaresch.高三尖杉酯碱对人淋巴瘤细胞系Raji细胞作用的实验研究[J].中华血液学杂志,2000,21(10):546-547. 被引量:5
共引文献17
-
1杨盛波,文海泉,张桂英,赵莎,罗勇奇,陆前进.雷公藤内酯醇上调纤维肉瘤HT-1080细胞基质金属蛋白酶-9基因甲基化水平[J].中国中药杂志,2009,34(5):611-614. 被引量:7
-
2佟红艳,林茂芳.5′-杂氮-2′-脱氧胞苷对高危组骨髓增生异常综合征细胞作用的体外研究[J].中国实验血液学杂志,2004,12(4):467-471. 被引量:7
-
3沈建箴,周华蓉.去甲基化在治疗恶性血液病中的研究[J].中华内科杂志,2006,45(5):355-356. 被引量:8
-
4伍洲炜,施伟民.DNA甲基转移酶1和CD11a基因在SLE患者中的表达[J].同济大学学报(医学版),2006,27(3):21-24. 被引量:7
-
5施伟民,伍洲炜,施若非,梅兴宇,秦海红,郑捷.DNA甲基转移酶与CD11a基因在SLE患者中的表达[J].中华皮肤科杂志,2007,40(7):431-433. 被引量:5
-
6曾国英,陈为民.雷公藤内酯醇抗血液系统恶性肿瘤机制研究进展[J].河北北方学院学报(医学版),2008,25(1):75-78.
-
7杨盛波,文海泉,张桂英,李胜华,陆前进.雷公藤内酯醇对纤维肉瘤HT-1080细胞DNA甲基转移酶1和3A表达的影响[J].中华皮肤科杂志,2008,41(7):480-481. 被引量:1
-
8吴雪梅,沈建箴,喻爱芳,范丽萍,付海英,沈松菲,吴淡森.雷公藤内酯醇对急性T淋巴细胞白血病Jurkat细胞系APC基因去甲基化诱导表达机制的研究[J].白血病.淋巴瘤,2009,18(6):327-330.
-
9王信峰,徐瑞容,杨力,姜胜华,丁润生,陆伟.地西他滨联合全反式维甲酸对SKM-1 MDS细胞株的体外研究[J].交通医学,2009,23(2):125-128. 被引量:4
-
10田慧(综述),徐燕丽(审校).甲基化转移酶抑制剂治疗急性髓系白血病的研究进展[J].国际输血及血液学杂志,2012,35(3):215-218. 被引量:4
同被引文献51
-
1Lyko F, Brown R. DNA methyltransferase inhibitors and the development of epigenetic cancer therapies[J]. J Natl Cancerlnst, 2005, 97(20) : 1 498.
-
2Nan X, Ng HH, Johnson CA, et al. Transcriptional repr- ession by the methyl CpG binding protein MeCP2 in- volves a hist one deacetylase complex[J]. Nature, 1998, 393(6 683) :386.
-
3Pakneshan P, Szyf M, Farias-Eisner R, et al. Reversal of the hypomethylation status of urokinase (uPA) promoter blocks breast cancer growth and metastasis[J]. J Biol Chem, 2004,279(30) :31 735.
-
4Edlin R, Connock M, Tubeuf S, et al. Azacitidine for the treatment of myelodysplastic syndrome, chronic myelo- monocytic leukaemia and acute myeloid leukaemia[J]. Health TechnolAssess, 2010,14(Suppl 1) :69.
-
5Issa JP. Decitabine[J]. Current Opinion in Oncology , 2003, 15(6) :446.
-
6Scott SA, Lakshimikuttysamma A, Sheridan DP, et al. Zebularine inhibits human acute myeloid leukemia cell growth in vitro in association with p154B demethylation and reexpression[J]. Exp Hematol, 2007,35(2) : 263.
-
7Gao Z, Xu Z, Hung MS, et al. Procaine and procainami- de inhibit the Wnt canonical pathway by promoter demeth- ylation of WIF-I in lung cancer cells[J]. Oncol Rep, 2009, 22(6) : 1479.
-
8Tada M, Imazeki F, Fukai K, et al. Procaine inhibits the proliferation and DNA methylation in human hepatoma cells[J]. Hepatol lnt, 2007, 1 (3) : 355.
-
9Arce C, Segura-Pacheco B, Perez-Cardenas E, et al. Hy- dralazine target: from blood vessels to the epigenome[J].J Transl Med, 2006, 4:10.
-
10Candelaria M, Gallardo-Rincon D, Arce C, et al. A ph- ase 1I study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resis- tance in refractory solid tumors[J]. Ann Oncol, 2007, 18 (9):1 529.
二级引证文献5
-
1马彦娥,韩福才.DNA甲基化在肺癌诊疗中的应用价值[J].医学综述,2013,19(24):4458-4460. 被引量:1
-
2谢锦艳,许苗苗,刘银环,宋蓓,刘越,刘海静,宋小妹.开口箭乙醇提取物诱导肝癌细胞HepG2凋亡活性研究[J].中南药学,2014,12(8):735-739. 被引量:3
-
3张敏,朱卫丰,嵇琴,孙振,周莹,章明,彭淑红.抗肿瘤中药对DNA去甲基化作用的研究进展[J].中国实验方剂学杂志,2015,21(23):224-229. 被引量:6
-
4周珍,柯浩亮,张莹雯,沈鑫.开口箭抗肿瘤作用研究进展[J].山东中医杂志,2018,37(8):706-708. 被引量:2
-
5郭玺,董坚.DNA甲基化在结直肠癌中的研究进展[J].西部医学,2019,31(1):157-160. 被引量:3
-
1王玉亭,王成东,张振兴.DNA甲基化异常与垂体瘤[J].神经疾病与精神卫生,2001,1(2):61-62. 被引量:1
-
2陈存华,杨俊鹏.恶性血液病去甲基化治疗的研究进展[J].中国实验血液学杂志,2009,17(5):1394-1398. 被引量:3
-
3王小瑞,张红伟,郭春林,王永福.去甲基化在胃癌中的研究进展[J].国际消化病杂志,2010,30(5):273-275.
-
4赵向前,赵霖,冯玉泉.DNA甲基化异常与肿瘤[J].肿瘤防治研究,1999,26(2):152-154. 被引量:1
-
5肖文华,刘为纹.DNA甲基化异常与肿瘤研究现状[J].肿瘤,1995,15(3):297-300. 被引量:1
-
6王旭,马莉,苏克举,曹洪明,何华,李薇.地西他滨单药及联合其他药物在实体肿瘤治疗中应用的研究进展[J].吉林大学学报(医学版),2015,41(4):870-873.
-
7范保星,张开泰,等.DNA甲基化与肿瘤[J].国外医学(分子生物学分册),2002,24(3):139-143. 被引量:6
-
8金哈斯.白血病DNA去甲基化治疗[J].国外医学(输血及血液学分册),1999,22(3):140-142. 被引量:1
-
9寿倍明,陈宝安,刘德龙.去甲基化在白血病上的研究进展[J].中国实验血液学杂志,2008,16(5):1247-1250. 被引量:11
-
10王亮,丛宪玲,佟雅军,蒋忠民.DNA甲基化异常与皮肤肿瘤[J].中国实验诊断学,2009,13(12):1812-1814.